What is Pharvaris BV (PHVS) stock price today?

Pharvaris BV (PHVS) currently trades at $30.09 per share. The stock has a market capitalization of $1.97B and a P/E ratio of —x.

Is PHVS stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Pharvaris BV has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is 4.04.

Is Pharvaris BV financially healthy?

Pharvaris BV's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of 4.04 places it in the safe zone.

PHVS

Pharvaris BV

NASDAQ: PHVS · HEALTHCARE · BIOTECHNOLOGY

$30.09

+1.38% today

Updated 2026-05-08

Market cap

$1.97B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.48

Dividend yield

—

52W range

$15 – $31

Volume

0.3M

Market cap

$1.97B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.48

Dividend yield

—

52W range

$15 – $31

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

8.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

4.0

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →194 stocks currently score above 75

Price targets

Analyst target

$46.86

+55.73%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

3 Strong Buy8 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Altman Z 4.04 — safe zone

+ Debt/equity 0.00x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-37.95M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	—
Net income	$-76.33M	$-100.88M	$-134.22M	$-175.70M	$-46.74M
EPS	—	—	—	—	$-3.48
Free cash flow	$-67.29M	$-93.14M	$-120.67M	$-137.24M	$-37.95M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PHVS	$1.97B	23	4.3	3.0	5.0	8.0	—	Avoid
LLY	$869.41B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$535.63B	59	4.7	9.0	3.3	6.0	-37.47%	Buy
ABBV	$358.55B	63	4.0	8.0	4.0	5.0	-19.74%	Buy
UNH	$335.78B	54	5.3	5.5	7.3	4.8	+40.60%	Buy
AZN	$286.68B	62	6.0	8.5	5.3	5.0	+6.60%	Buy

Smart narrative

Pharvaris BV trades at $30.09. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 4.04, it sits in the safe zone.

Frequently asked questions

What is Pharvaris BV's stock price?

Pharvaris BV (PHVS) trades at $30.09.

Is Pharvaris BV overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of Pharvaris BV (PHVS)?

The analyst target price is $46.86, representing +55.7% upside from the current price of $30.09.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

4.04 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

pharvaris.com

Quick metrics

P/S ratio—

ROE-65.20%

Beta-2.34

50D MA$27.77

200D MA$25.08

Shares out0.07B

Float0.04B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PHVS vs LLY →PHVS vs JNJ →PHVS vs ABBV →Stock screener →